Clinical profile and outcome of secondary glaucoma managed during the COVID-19 pandemic in a tertiary care institute

Table 1 Intraocular pressure at the presentation of various types of secondary glaucoma

		Type of secondary glaucoma								Total
		PXF	Trauma	NVG	LIG	SIG	Uveitic	Developmental	Others
IOP at presentation in mmHg, %	≤ 20	2	0	0	0	4	0	0	0	6
		9.1	0.0	0.0	0.0	40.0	0.0	0.0	0.0	7.3
	21-30	8	5	3	3	2	2	2	4	29
		36.4	45.5	21.4	42.9	20.0	50.0	40.0	44.4	35.4
	31-40	9	3	8	1	2	1	2	3	29
		40.9	27.3	57.1	14.3	20.0	25.0	40.0	33.3	35.4
	> 40	3	3	3	3	2	1	1	2	18
		13.6	27.3	21.4	42.9	20.0	25.0	20.0	22.2	22.0
Total		22	11	14	7	10	4	5	9	82
		100.0	100.0	100.0	100.0	100.0	100.0	100.0	100.0	100.0

IOP: Intraocular pressure; PXF: Pseudoexfoliation; LIG: Lens induced glaucoma; NVG: Neovascular glaucoma; SIG: Steroid induced glaucoma.

Table 2 Mean intraocular pressure at presentation and at follow-up (descriptive statistics)

	mean ± SD	n	F value	P value
IOP in mmHg at presentation	34.72 ± 10.46	82	201.64	0.0001
At 1 week	18.65 ± 7.27	82
At 1 month	16.71 ± 6.42	82
At 3 months	16.63 ± 5.39	82
At 6 months	16.65 ± 7.22	82

IOP: Intra ocular pressure.

Table 3 Secondary glaucoma presentation during coronavirus disease 2019 pandemic and post pandemic period, n (%)

	COVID-19	Post COVID-19	P value
Number of patients	62	82
Number of eyes affected	82	110	0.86
Male:female ratio	2.8:1	1.8:1	0.79
PXF	22 (26.8)	20 (18.2)	0.04
NVG	14 (17.1)	30 (27.3)
Traumatic	11 (13.4)	12 (10.9)
SIG	10 (12.2)	16 (14.5)
LIG	7 (8.5)	0 (0.00)
Developmental	5 (6.1)	9 (8.2)
Uveitic	4 (4.9)	10 (9.1)
Miscellaneous	9 (11.0)	13 (11.8)
Medical management in percentage	59 (71.9)	66 (60.0)	0.07
Surgical management in percentage	23 (28.1)	44 (40.00)
Mean IOP at presentation in mmHg	34.7 ± 10.46	35.2 ± 9.46	0.73
Mean IOP at 6 months in mmHg	16.65 ± 7.22	14.95 ± 6.45	0.087

IOP: Intraocular pressure; PXF: Pseudoexfoliation; LIG: Lens induced glaucoma; NVG: Neovascular glaucoma; SIG: Steroid induced glaucoma; COVID-19: Coronavirus disease 2019.